|
Jun 29
|
BioNTech and OncoC4 Initiate Pivotal Phase 3 Trial of BNT316/ONC-392 Program in Metastatic NSCLC
|
|
May 25
|
BioNTech's Ready-to-Use Single Dose Vaccine, the Perfect Counterattack to China's Rising XBB1.5 Cases
|
|
May 25
|
BioNTech is proceeding with COVID-shot in line with WHO guidance
|
|
May 23
|
2 Undervalued Stocks to Buy for Potentially Massive Gains in the Next 10 Years
|
|
May 19
|
Are Options Traders Betting on a Big Move in BioNTech (BNTX) Stock?
|
|
May 19
|
CureVac files expanded patent lawsuit against Pfizer/BioNTech over mRNA technology
|
|
May 19
|
UPDATE 1-CureVac files expanded patent lawsuit against Pfizer/BioNTech over mRNA technology
|